Malignant mixed mullerian tumor of the ovary: report of four cases

Introduction: Malignant mixed mullerian tumor (MMMT) of the ovary is an extremely rare gynaecologic neoplasm that represents 1% of the malignances of this organ. Stage I disease is rare because it is asymptomatic in early stage. We describe four cases.

Case reports: In the Department of Obstetrics and Gynecology of the University of Bari four cases of MMMT of the ovary were diagnosed. Three patients were in stage IIIC and one of them was a homologous MMMT; the fourth patient was affected by a heterologous stage IV MMMT. All women were treated with surgery and chemotherapy. Two patients are alive 14 and 12 months after diagnosis. The other two died after 37 months and one month, respectively.

Conclusions: The malignant mixed mullerian tumor (MMMT) of the ovary is a particularly aggressive tumor, especially in advanced stages. The survival rate is very low in spite of surgery, chemotherapy and radiotherapy. The optimal treatment for this neoplasm is unknown because of its rarity. Our experience, when considering survival, seems to confirm the use of cisplatin and ifosfamide and to give new horizons to taxol.

Ovarian cancer; Ovarian MMMT

[1] Morrow C. P., D'Ab laing G., Blady L. W.: "A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors. A Gynecologic Oncology Group Study". Gynecol. Oneal., 1994, 18, 278.

[2] Terada K. Y., Yohnson T. L., Hopkins M.: "Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas" Gynecol. Oneal., 1989, 32, 228.

[3] Ostor A.G.: "Sarcoma degli organi molli anatomia patologica" In: "Surgical Gynecologic Oncology". Ed. Burghardi F. Theme, 1994, 397.

[4] Carlon J. A., Edwards C., Wharton J. T.: "Mixed mesodermal sarcoma of ovary: treatment with combination radiation therapy and chemotherapy". Cancer, 1983, 52, 1473.

[5] Plaxe S. C.: "Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin and cisplatinum based chemotherapy". Gynecol. Oneal., 1990, 37, 244

[6] Moore M., Fine S., Sturgeon L: "Malignant mixed mesodermal tumors (MMMT) of the ovary. The Princess Margaret Hospital (PMH) experience”. J Clin. Oncol., 1986, 5, 114.

[7] Dictor M,: "Mixed mesodermal tumor of the ovary: a report of 22 cases". Ohstet. Gynecol., 1985, 65, 720.

[8] Patsner B., Greenberg S.: "Mesna, Doxorubicin, Ifosfamide and Dacarbazine chemotherapy for ovarian mixed mullerian sarcoma: report of four cases". Gynecol Oneal., 1995, 58, 386.